// App-Quantinova.ai

3946 : Secretory ANXA3 endows liver cancer cells with tumorigenic and self-renewal abilities and promotes HCC development

Researchers

Presenter

  • Man Tong

Principal Investigators

  • Stephanie Ma

Medical Centers

  • Univ. of Hong Kong, Faculty of Medicine, Pokfulam, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Alpha-fetoprotein

  • c-Jun N-terminal kinase

  • JunB proto-oncogene, AP-1 transcription factor subunit

  • X-linked inhibitor of apoptosis

Drug/Treatment

  • Alfa-fetoprotein

  • staurosporine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved